The trial supported by the Soupy for Loopy Foundation will use bevacizumab (AvastinTM) and zoledronic acid (Zometa®) with low doses of the chemotherapeutic agent cyclophosphamide (cytoxan). Referred as N0702,
Funds will support NANT 2013-02 Phase I Study of Sorafenib with Cyclophosphamide and Topotecan in Patients with Relapsed and Refractory Neuroblastoma.
Shop at AmazonSmile and Amazon will donate
to Soupy for Loopy
New Approaches to Neuroblastoma Therapy (NANT)
SOUPY FOR LOOPY is a registered servicemark of Soupy for Loopy Foundation, Inc. Copyright 2007-2018 Soupy for Loopy Foundation, Inc. All rights reserved.